The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization

Vaccine

Volumn 31, Issue S9, 2013, Pages

  Kane, M A ^a   Hadler, S C ^b   Lee, L ^c   Shapiro, C N ^d   Cui, F ^e   Wang, X ^f   Kumar, R ^g  

^a Consultant on Immunization Policy ^*  (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c medical consultant   (United States)

^d U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f The World Health Organization Regional Office for the Western Pacific philippines   (Philippines)

^g GAVI Alliance   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE;

ALCOHOL LIVER DISEASE; AWARENESS; BUDGET; CATCH UP GROWTH; CHILDBIRTH; CHINA; DRUG COST; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; FINANCIAL MANAGEMENT; GOVERNMENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEPATITIS B; HOME DELIVERY; HOSPITAL; HUMAN; INCOME; INDIA; INDONESIA; INFECTION PREVENTION; LIVER CANCER; LIVER CIRRHOSIS; MASS IMMUNIZATION; PARENT; POVERTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLIC HOSPITAL; REVIEW; SYRINGE; WASTE DISPOSAL;

CARCINOMA, HEPATOCELLULAR; CHINA; COMMUNICABLE DISEASE CONTROL; HEALTH POLICY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INTERNATIONAL COOPERATION; LIVER CIRRHOSIS;

EID: 84892395401     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.045     Document Type: Review

References (25)

1. UNICEF Sustainability of achievements: lessons learned from universal childhood immunization. Report of a Steering Committee 1996, (accessed 13.08.12). http://immunizationbasics.jsi.com/Docs/BASICS/UCISustainabilityReport.pdf.
2. Melgaard B. Immunization and health reform: the implications of decentralisation. Paper presented to the Scientific Advisory Group of Experts (SAGE), Geneva, 9-11 June 1998. Document reference GPV-CVI/SAGE.98/WP.13. Geneva: World Health Organization; 1998.
3. Levine R. Should all vertical programs just lie downα 2007, October, Center for Global Development, (accessed 14.08.12). http://blogs.cgdev.org/globalhealth/2007/10/should-all-vertical-programs-j.php.
4. Msuya J. Horizontal and vertical delivery of health services: what are the trade offsα 2005, The World Bank, (accessed 14.08.12). http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2003/10/15/000160016_20031015125129/additional/310436360_200502761000211.pdf.
5. GAVI Origins of GAVI 2012, (accessed 25.08.12). http://www.gavialliance.org/about/mission/origins/.
6. MOH National review on national immunization programme in 2004 2005, People Health Express.
7. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200(1):J39-J47.
8. Cui F., Luo H., Wang F., Zheng H., Gong X., Chen Y., et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 2013, 31:J36-J42.
9. Cui F.Q., Liang X.F., Gong X.H., Chen Y.S., Wang F.Z., Zheng H., et al. Preventing hepatitits B through universal vaccination: reduction of inequalities through the China GAVI Project. Vaccine 2013, 31:J29-J35.
10. Liang X., Cui F., Hadler S., Wang X., Luo H., Chen Y., et al. Origins, design and implementation of the China GAVI project. Vaccine 2013, 31:J8-J14.
11. WHO. Hepatitis B. Fact sheet N° 204 July 2012. (accessed 13.08.12). http://www.who.int/mediacentre/factsheets/fs204/en/.
12. Vagelos P.R., Galambos L. The moral corporation: Merck experiences 2006, Cambridge University Press, Cambridge, UK.
13. WHO. A system for the prequalification of vaccines for UN supply. (accessed 27.09.12). http://www.who.int/immunization_standards/vaccine_quality/pq_system/en/index.html.
14. World Health Organization China International Review of the Expanded Programme on Immunizations in China 2005, Beijing Reizhe Publishing House, Beijing.
15. England S., Kaddar M., Nigam A., Pinto M. Practice and policies on user fees for immunization in developing countries. WHO/V&B/01.07 2001, World Health Organization, Geneva.
16. Xu X. The impact of SARS on China. Seton Hall Journal of Diplomacy and International Relations 2003, (accessed 15.08.12). http://www.isn.ethz.ch/isn/Digital-Library/Publications/Detail/%3Fots591=0c54e3b3-1e9c-be1e-2c24-a6a8c7060233%26lng=en%26id=29725.
17. Wang S.S., Xu Z.Y., Maynard J.E., Prince A.M., Beasley R.P., Yang J.Y., et al. Evaluation of the hepatitis B model immunization program in Long'an County, China. J Guangxi Prev Med (Chin) 1995, 1:1-4.
18. Wang L., Li J., Chen H., Li F., Armstrong G.L., Nelson C., et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ 2007, 85:688-694.
19. World Health Organization Regional Office for the Western Pacific Preventing mother-to child transmission of hepatitis B. Operational field guidelines for delivery of the birth dose of hepatitis B vaccine 2006, World Health Organization Regional Office for Western Pacific, Manila, Philippines.
20. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database of Syst Rev 2006, 2:CD004790. (Online).
21. Hu Y., Zhang S., Luo C., Liu Q., Zhou Y.-H. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infect Dis 2012, 12:221.
22. Simonsen L., Kane A., Lloyd J., Zaffran M., Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999, 77(10):789-800.
23. Levin A., Pyle D., Dia O., Rock M., Callahan R. Evaluation of GAVI's injection safety support 2008, JSI R&T, Arlington, VA.
24. Wu Z., Cui F., Chen Y., Miao N., Gong X., Luo H., et al. Evaluation of immunization injection safety in China, 2010: achievements, future sustainability. Vaccine 2013, 31:J43-J48.
25. European Association for the Study of the Liver. Revised Clinical Practice Guidelines on the Management of Chronic Hepatitis B. Issue 8 (April 2012). (accessed 17.08.12). http://www.easl.eu/_clinical-practice-guideline/issue-8-april-2012-revised-clinical-practice-guidelines-on-the-management-of-chronic-hepatitis-B.